# GRAIL

> early cancer detection technology

Business model and tags: B2C, Has physical offices, Publicly traded, AI & machine learning, Pharma & life sciences, Medical devices, Multi-site, International operations, Has in-house R&D, Handles regulated data

## About GRAIL

Developing innovative technologies using sequencing and data science to detect cancer early, improving treatment outcomes and reducing mortality.

## Key facts

- **Industry**: Biotechnology Research
- **Company size**: 1,001–5,000 employees
- **Headquarters**: Menlo Park, California, United States
- **Founded**: 2016
- **Revenue**: $46.4M – $366M (Tamtam estimate)
- **Website**: [grail.com](https://grail.com/)
- **LinkedIn**: [linkedin.com/company/grail-inc.](https://www.linkedin.com/company/grail-inc.)

## GRAIL at a glance

GRAIL is a B2C company in the Biotechnology Research industry, headquartered in Menlo Park, California, United States.

GRAIL was founded in 2016.

GRAIL has 1,001–5,000 employees.

GRAIL's revenue is $46.4M – $366M (Tamtam estimate).

## Frequently asked questions about GRAIL

### What is GRAIL's revenue?

Tamtam estimates GRAIL's annual revenue at $46.4M – $366M.

### How many employees does GRAIL have?

GRAIL has 1,001–5,000 employees.

### Where is GRAIL headquartered?

GRAIL is headquartered in Menlo Park, California, United States.

---

Company data compiled by Tamtam from public sources and Tamtam's own analysis. Figures marked as estimates are modelled, not reported.

Source: https://www.tamtam.ai/c/grail
